How to check online; also know the BPF

Supriya Lifescience’s IPO had been taken up 71.51 times at the end of the show. Here’s all about award status.

A day after Supriya Lifescience Limited’s three-day Initial Public Offering (IPO) closed, a pharmaceutical ingredients supplier is trading at a 47% premium on the gray market, according to data from IPO Watch. Supriya Lifescience’s GMP value dominates at ??130 in the gray market today, according to data from IPO Watch. Offers for shares were received against shares offered on the initial sale.

At the end of Monday’s public issue day, the issue had been subscribed 71.51 times due to strong investor demand. Retail investors have offered 56 times the amount planned for them. The quota for non-institutional investors was subscribed 161 times, while the limit for qualified institutional investors was subscribed 31.8 times. The price range of the issue was set at ??265-274 per share. Before its IPO, the company had raised ??315 crore from key investors.

When can we expect allotment status?

Bidders who have subscribed to the public offering of Supriya Lifescience Limited, can expect the allotment of the shares by this Thursday, i.e. December 23. If the allotment takes place on the scheduled date, then the shares will be credited to the investors’ demat accounts on December 27th.

How to check the award status of Supriya Lifescience IPO shares?

People who have subscribed to the Supriya Lifescience IPO can check the status online after the announcement on the Bombay Stock Exchange (BSE) website through this link – investors / appli_check.aspx. Access the Actions option under issue type. Click Equity under Issue Type option and enter the name of the show which is Supriya Lifescience IPO. Then enter your application number and your PAN number. Hit the search button and go! You will get your IPO status on your screens.

In addition to the ESB website, you can also check the allotment status on the Link Intime India Private Limited website through this link –

Supriya Lifescience Details

Supriya, which was founded in 2008, had 38 APIs as of October, with a focus on the antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic segments. Between FY17 and FY21, it is the leading exporter of chlorpheniramine maleate and ketamine hydrochloride, accounting for 45-50% and 60-65% of API shipments from India, respectively.

Comments are closed.